Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
Condition: Open Posterior Thoracolumbar Spinal Fusion Procedure Interventions: Drug: Tranexamic Acid Injectable Product (1000 mg intravenous bolus); Drug: Vitamin C 250 MG Oral Tablet; Drug: Tranexamic Acid 650Mg Tablet Sponsor: Rush University Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Blood Transusion | Research